News

Applied Clinical Trials Online44m
Kisunla Slows Cognitive and Functional Decline Over Three Years in Phase III Alzheimer Long-Term Extension Trial
Results from the long-term extension of the Phase III TRAILBLAZER-ALZ 2 trial (NCT04437511) showed sustained benefits with ...
Hibernation’s Hidden Healing ‘Superpowers’ Could Be Locked in Our DNA
Scientists found genetic elements linked to hibernation in the human genome. Tapping into them could produce a new wave of ...
Scots chemist believes drugs to treat Alzheimer's will be available in five years
A Scots chemist believes drugs to treat Alzheimer's disease will be available within five years. Professor David MacMillan, ...